1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends
  5. > Novian Health, Inc. - Product Pipeline Analysis, 2016 Update

Summary

Novian Health Inc. (Novian) is a medical device company that develops invasive surgical devices and procedures to the healthcare sector. The company develops proprietary technology for the minimally invasive treatment of tumors using interstitial laser therapy. Its Novilase breast therapy uses parametrically controlled heating to ablate breast tumors under ultrasound and stereotactic x-ray image guidance. Novian offers services such as image guided laser ablation, pipeline research and development, feasibility and technology development and demonstration, commercialization, pre clinical validation, and others. The company therapeutic areas include treatment of breast cancer, liver cancer, immunotherapy, breast tumors, and others. It operates in the US and France. Novian is headquartered in Chicago, Illinois, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Novian Health, Inc.
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Table Of Contents

Novian Health, Inc. - Product Pipeline Analysis, 2016 Update
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Novian Health, Inc. Company Snapshot 5
Novian Health, Inc. Company Overview 5
Key Information 5
Novian Health, Inc. Pipeline Products and Clinical Trials Overview 6
Novian Health, Inc. - Major Products and Services 8
Novian Health, Inc. Pipeline Products by Development Stage 9
Novian Health, Inc. Clinical Trials by Trial Status 11
Novian Health, Inc. Pipeline Products Overview 13
Novilase ILT (Interstitial Laser Therapy) - Malignant Breast Tumor Therapy 13
Novilase ILT (Interstitial Laser Therapy) - Malignant Breast Tumor Therapy Product Overview 13
Novilase ILT (Interstitial Laser Therapy) - Malignant Breast Tumor Therapy Clinical Trial 14
Novilase ILT - Liver Cancer 15
Novilase ILT - Liver Cancer Product Overview 15
Novilase ILT - Prostate Cancer 16
Novilase ILT - Prostate Cancer Product Overview 16
Novilase ILT - Skin Cancer 17
Novilase ILT - Skin Cancer Product Overview 17
Novian Health, Inc. - Key Competitors 18
Novian Health, Inc. - Key Employees 19
Novian Health, Inc. - Locations And Subsidiaries 20
Head Office 20
Recent Developments 21
Novian Health, Inc., Recent Developments 21
Dec 11, 2015: Breast Cancer Clinical Trial of Laser Ablation Treatment Shows Promising Results for Patients 21
Sep 09, 2014: Walter Reed Bethesda Joins Novilase Clinical Trial 22
Sep 02, 2014: Novian Health Wins Acclaim from Frost and Sullivan for Novilase Interstitial Laser Ablation Therapy for Early-Stage Malignant Breast Tumors 22
Dec 05, 2013: Novian Health Awarded New Patent for Breast Cancer Treatment Technology 23
Apr 12, 2012: Novian Health Begins Breast Cancer Clinical Trial On Novilase Interstitial Laser Therapy System 24
Sep 28, 2011: Novian Health Receives New Patent For Breast Tumor Treatment Technology 24
Jul 14, 2011: Novian Health Receives FDA Approval To Study Novilase Interstitial Laser Therapy System 25
Nov 04, 2010: Novian Health Wins $244,479 Grant Under QTDP Program 25
Nov 18, 2009: Novian Health Signs Agreement With Tower Radiology Center In Tampa Bay 26
Oct 29, 2009: Novian Health Announces Agreement With Rose Medical Center In Denver 26
Appendix 27
Methodology 27
About GlobalData 27
Contact Us 27
Disclaimer 27

List of Tables
Novian Health, Inc., Key Facts 5
Novian Health, Inc. Pipeline Products and Clinical Trials Overview 6
Novian Health, Inc. Pipeline Products by Equipment Type 6
Novian Health, Inc. Pipeline Products by Indication 7
Novian Health, Inc. Clinical Trials by Trial Status 7
Novian Health, Inc., Major Products and Services 8
Novian Health, Inc. Number of Pipeline Products by Development Stage 9
Novian Health, Inc. Pipeline Products Summary by Development Stage 10
Novian Health, Inc. Clinical Trials by Trial Status 11
Novian Health, Inc. Clinical Trials Summary 12
Novilase ILT (Interstitial Laser Therapy) - Malignant Breast Tumor Therapy - Product Status 13
Novilase ILT (Interstitial Laser Therapy) - Malignant Breast Tumor Therapy - Product Description 13
Novilase ILT (Interstitial Laser Therapy) - Malignant Breast Tumor Therapy - A Multicenter "Ablate and Resect" Study of Novilase Interstitial Laser Therapy for the Ablation of Small Breast Cancers 14
Novilase ILT (Interstitial Laser Therapy) - Malignant Breast Tumor Therapy - American Breast Laser Ablation Therapy Evaluation (ABLATE): Monitoring the Long Term Safety and Efficacy of Novilase Breast Interstitial Laser Therapy in Real World Application 14
Novilase ILT (Interstitial Laser Therapy) - Malignant Breast Tumor Therapy - Local Treatment by Thermic Destruction of Primitive Breast Cancer. Phase II: Feasibility and Effectiveness, Standardization of Procedures 14
Novilase ILT - Liver Cancer - Product Status 15
Novilase ILT - Liver Cancer - Product Description 15
Novilase ILT - Prostate Cancer - Product Status 16
Novilase ILT - Prostate Cancer - Product Description 16
Novilase ILT - Skin Cancer - Product Status 17
Novilase ILT - Skin Cancer - Product Description 17
Novian Health, Inc., Key Employees 19

List of Figures
Novian Health, Inc. Pipeline Products by Equipment Type 7
Novian Health, Inc. Pipeline Products by Development Stage 9
Novian Health, Inc. Clinical Trials by Trial Status 11

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Aryl Hydrocarbon Receptor (Class E Basic Helix Loop Helix Protein 76 or bHLHe76 or AHR) - Pipeline Review, H2 2016

Aryl Hydrocarbon Receptor (Class E Basic Helix Loop Helix Protein 76 or bHLHe76 or AHR) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • August 2016
  • by Global Markets Direct

Aryl Hydrocarbon Receptor (Class E Basic Helix Loop Helix Protein 76 or bHLHe76 or AHR) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Aryl Hydrocarbon Receptor (Class E Basic Helix Loop ...

Histone Deacetylase 1 (HDAC1 or EC 3.5.1.98) - Pipeline Review, H2 2016

Histone Deacetylase 1 (HDAC1 or EC 3.5.1.98) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • October 2016
  • by Global Markets Direct

Histone Deacetylase 1 (HDAC1 or EC 3.5.1.98) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Histone Deacetylase 1 (HDAC1 or EC 3.5.1.98) - Pipeline Review, H2 2016’, provides in depth ...

Oligodendroglioma - Pipeline Review, H2 2016

Oligodendroglioma - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • September 2016
  • by Global Markets Direct

Oligodendroglioma - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Oligodendroglioma - Pipeline Review, H2 2016’, provides an overview of the Oligodendroglioma pipeline landscape. The ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.